Using DealForma insights, PharmaShots names Novo Nordisk Dealmaker of the Year 2024, highlighting 24 deals worth $33.94B led by the $16.5B Catalent acquisition. Read it here
Using DealForma insights, PharmaShots names Novo Nordisk Dealmaker of the Year 2024, highlighting 24 deals worth $33.94B led by the $16.5B Catalent acquisition. Read it here
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
